Search
-
Corporate reporting 2014
Investors
Corporate reporting 2014
https://www.gsk.com/en-gb/investors/financial-reports/corporate-reports-archive/corporate-reporting-2014/
First published: 16 March 2015
-
Responsible business reports 2014
Responsibility
Responsible business reports 2014
https://www.gsk.com/en-gb/responsibility/esg-resources/esg-reports-archive/responsible-business-reports-2014/
First published: 01 March 2015
-
Investor Event at ERS 2014, Munich
Investors
Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a presentation and Q&A.
https://www.gsk.com/en-gb/investors/speeches-and-presentations/investor-event-at-ers-2014-munich/
First published: 24 February 2014
-
Results announcement for the fourth quarter 2014
Media
GSK delivers 2014 core EPS of 95.4p (-1% CER excluding divestments) and dividend of 80 pence per share (+3%)
https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-fourth-quarter-2014/
First published: 04 February 2015
-
Results announcement for the second quarter 2014
Media
GSK delivers Q2 2014 turnover £5.6 billion (-4%) and core EPS 19.1p (-12%) on ex-divestment basis (both CER). Q2 dividend 19p (+6%).
https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-second-quarter-2014/
First published: 23 July 2014
-
GSK kicks off 2014 Discovery Fast Track Challenge for academic drug hunters in Europe, Canada and USA
Media
GSK is inviting academic scientists to enter their most innovative drug research proposals into its 2014 Discovery Fast Track Challenge.
https://www.gsk.com/en-gb/media/press-releases/gsk-kicks-off-2014-discovery-fast-track-challenge-for-academic-drug-hunters-in-europe-canada-and-usa/
First published: 25 February 2014
-
Results announcement for the first quarter 2014
Media
Q1 turnover £5.6 billion, -2% (CER) on an ex-divestment* basis.
https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-first-quarter-2014/
First published: 30 April 2014
-
Results announcement for the third quarter 2014
Media
GSK announces Q3 core EPS of 27.9p +5% CER excluding divestments and dividend of 19 pence per share
https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-the-third-quarter-2014/
First published: 22 October 2014
-
GSK leads Access to Medicine Index 2014
Media
The Access to Medicines Index published today has ranked GSK top for the fourth consecutive time.
https://www.gsk.com/en-gb/media/press-releases/gsk-leads-access-to-medicine-index-2014/
First published: 17 November 2014
-
GSK names winners of 2014 Discovery Fast Track Challenge
Media
GSK announced the winners of its second Discovery Fast Track Challenge for academic researchers & drug discovery scientists at GSK
https://www.gsk.com/en-gb/media/press-releases/gsk-names-winners-of-2014-discovery-fast-track-challenge/
First published: 01 December 2014